TEVA logo

TEVA Short term debt

Annual short term debt:

$1.78B+$109.00M(+6.52%)
December 31, 2024

Summary

  • As of today (June 1, 2025), TEVA annual short term debt is $1.78 billion, with the most recent change of +$109.00 million (+6.52%) on December 31, 2024.
  • During the last 3 years, TEVA annual short term debt has risen by +$355.00 million (+24.89%).
  • TEVA annual short term debt is now -58.39% below its all-time high of $4.28 billion, reached on December 31, 2011.

Performance

TEVA Short term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAbalance sheet metrics

quarterly short term debt:

$421.00M-$1.36B(-76.36%)
March 31, 2025

Summary

  • As of today (June 1, 2025), TEVA quarterly short term debt is $421.00 million, with the most recent change of -$1.36 billion (-76.36%) on March 31, 2025.
  • Over the past year, TEVA quarterly short term debt has dropped by -$2.64 billion (-86.24%).
  • TEVA quarterly short term debt is now -90.36% below its all-time high of $4.37 billion, reached on March 31, 2012.

Performance

TEVA quarterly short term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAbalance sheet metrics

Short term debt Formula

Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings

TEVA Short term debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+6.5%-86.2%
3 y3 years+24.9%-79.7%
5 y5 years-24.1%-74.2%

TEVA Short term debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-15.6%+24.9%-86.2%at low
5 y5-year-44.1%+24.9%-88.1%at low
alltimeall time-58.4%>+9999.0%-90.4%+2763.9%

TEVA Short term debt History

DateAnnualQuarterly
Mar 2025
-
$421.00M(-76.4%)
Dec 2024
$1.78B(+6.5%)
$1.78B(-31.0%)
Sep 2024
-
$2.58B(+23.2%)
Jun 2024
-
$2.09B(-31.6%)
Mar 2024
-
$3.06B(+83.0%)
Dec 2023
$1.67B(-20.7%)
$1.67B(+13.0%)
Sep 2023
-
$1.48B(-25.3%)
Jun 2023
-
$1.98B(+93.5%)
Mar 2023
-
$1.02B(-51.5%)
Dec 2022
$2.11B(+47.9%)
$2.11B(-23.8%)
Sep 2022
-
$2.77B(+61.1%)
Jun 2022
-
$1.72B(-17.2%)
Mar 2022
-
$2.08B(+45.7%)
Dec 2021
$1.43B(-55.3%)
$1.43B(-47.4%)
Sep 2021
-
$2.71B(-23.3%)
Jun 2021
-
$3.53B(+30.9%)
Mar 2021
-
$2.70B(-15.4%)
Dec 2020
$3.19B(+35.9%)
$3.19B(+51.4%)
Sep 2020
-
$2.11B(+27.7%)
Jun 2020
-
$1.65B(+1.2%)
Mar 2020
-
$1.63B(-30.5%)
Dec 2019
$2.35B(+5.8%)
$2.35B(-25.1%)
Sep 2019
-
$3.13B(+13.0%)
Jun 2019
-
$2.77B(-0.7%)
Mar 2019
-
$2.79B(+25.9%)
Dec 2018
$2.22B(-39.2%)
$2.22B(-17.1%)
Sep 2018
-
$2.67B(+110.1%)
Jun 2018
-
$1.27B(-2.3%)
Mar 2018
-
$1.30B(-64.3%)
Dec 2017
$3.65B(+11.3%)
$3.65B(+33.5%)
Sep 2017
-
$2.73B(+119.2%)
Jun 2017
-
$1.25B(-35.8%)
Mar 2017
-
$1.94B(-40.7%)
Dec 2016
$3.28B(+106.7%)
$3.28B(-10.9%)
Sep 2016
-
$3.68B(+27.6%)
Jun 2016
-
$2.88B(+82.3%)
Mar 2016
-
$1.58B(-0.3%)
Dec 2015
$1.58B(-10.0%)
$1.58B(-26.2%)
Sep 2015
-
$2.15B(-28.9%)
Jun 2015
-
$3.02B(+85.9%)
Mar 2015
-
$1.63B(-7.7%)
Dec 2014
$1.76B(-2.4%)
$1.76B(-3.9%)
Sep 2014
-
$1.83B(-10.5%)
Jun 2014
-
$2.05B(+32.0%)
Mar 2014
-
$1.55B(-14.0%)
Dec 2013
$1.80B(-40.0%)
$1.80B(-28.9%)
Sep 2013
-
$2.54B(+0.1%)
Jun 2013
-
$2.53B(-6.8%)
Mar 2013
-
$2.72B(-9.5%)
Dec 2012
$3.01B(-29.8%)
$3.01B(+172.8%)
Sep 2012
-
$1.10B(-22.4%)
Jun 2012
-
$1.42B(-67.5%)
Mar 2012
-
$4.37B(+2.0%)
Dec 2011
$4.28B(+54.5%)
$4.28B(+12.2%)
Sep 2011
-
$3.81B(+55.2%)
Jun 2011
-
$2.46B(+31.0%)
Mar 2011
-
$1.88B(-32.3%)
Dec 2010
$2.77B
$2.77B(+15.1%)
Sep 2010
-
$2.41B(+23.7%)
Jun 2010
-
$1.95B(-1.4%)
DateAnnualQuarterly
Mar 2010
-
$1.97B(+51.7%)
Dec 2009
$1.30B(-55.2%)
$1.30B(-11.9%)
Sep 2009
-
$1.48B(-27.2%)
Jun 2009
-
$2.03B(-39.6%)
Mar 2009
-
$3.36B(+15.5%)
Dec 2008
$2.91B(+57.8%)
$2.91B(+290.6%)
Sep 2008
-
$744.00M(-47.9%)
Jun 2008
-
$1.43B(-29.7%)
Mar 2008
-
$2.03B(+10.4%)
Dec 2007
$1.84B(+148.1%)
$1.84B(-5.7%)
Sep 2007
-
$1.95B(+28.1%)
Jun 2007
-
$1.52B(+0.2%)
Mar 2007
-
$1.52B(+105.0%)
Dec 2006
$742.00M(+97.3%)
$742.00M(+0.7%)
Sep 2006
-
$737.20M(-30.2%)
Jun 2006
-
$1.06B(-0.6%)
Mar 2006
-
$1.06B(+182.4%)
Dec 2005
$376.00M(-32.9%)
$376.00M(-3.6%)
Sep 2005
-
$390.00M(-7.0%)
Jun 2005
-
$419.50M(-16.5%)
Mar 2005
-
$502.60M(-10.3%)
Dec 2004
$560.00M(-13.1%)
$560.00M(+25.8%)
Sep 2004
-
$445.20M(-35.9%)
Jun 2004
-
$694.30M(-2.0%)
Mar 2004
-
$708.30M(+10.0%)
Dec 2003
$644.20M(-12.8%)
$644.20M(-44.4%)
Sep 2003
-
$1.16B(+46.7%)
Jun 2003
-
$789.90M(+2.5%)
Mar 2003
-
$770.50M(+4.3%)
Dec 2002
$738.50M(+257.6%)
$738.50M(+349.5%)
Sep 2002
-
$164.30M(+8.3%)
Jun 2002
-
$151.70M(-2.3%)
Mar 2002
-
$155.30M(-24.8%)
Dec 2001
$206.52M(-39.5%)
$206.52M(-0.3%)
Sep 2001
-
$207.10M(+7.3%)
Jun 2001
-
$192.95M(-12.0%)
Mar 2001
-
$219.30M(-35.8%)
Dec 2000
$341.52M(+23.6%)
$341.52M(-33.6%)
Jun 2000
-
$514.06M(+77.8%)
Mar 2000
-
$289.13M(+4.7%)
Dec 1999
$276.26M(-14.9%)
$276.26M(-36.7%)
Sep 1999
-
$436.60M(+52.6%)
Jun 1999
-
$286.10M(-10.3%)
Mar 1999
-
$319.10M(-1.7%)
Dec 1998
$324.50M(+35.3%)
$324.50M(-2.3%)
Sep 1998
-
$332.30M(+24.9%)
Jun 1998
-
$266.10M(+21.3%)
Mar 1998
-
$219.30M(-8.5%)
Dec 1997
$239.80M(-29.7%)
$239.80M(-29.7%)
Dec 1996
$341.20M(+33.7%)
$341.20M(+33.7%)
Dec 1995
$255.20M(+84.5%)
$255.20M(+84.5%)
Dec 1994
$138.30M(+26.5%)
$138.30M(+26.5%)
Dec 1993
$109.30M(+13.0%)
$109.30M(+13.0%)
Dec 1992
$96.70M(+69.4%)
$96.70M(+69.4%)
Dec 1991
$57.10M(+3.1%)
$57.10M(+3.1%)
Dec 1990
$55.40M(+122.5%)
$55.40M(+122.5%)
Dec 1989
$24.90M(-27.6%)
$24.90M(-27.6%)
Dec 1988
$34.40M(+134.0%)
$34.40M(+134.0%)
Mar 1987
$14.70M(0.0%)
$14.70M(0.0%)
Mar 1986
$14.70M
$14.70M

FAQ

  • What is Teva Pharmaceutical Industries Limited annual short term debt?
  • What is the all time high annual short term debt for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited annual short term debt year-on-year change?
  • What is Teva Pharmaceutical Industries Limited quarterly short term debt?
  • What is the all time high quarterly short term debt for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited quarterly short term debt year-on-year change?

What is Teva Pharmaceutical Industries Limited annual short term debt?

The current annual short term debt of TEVA is $1.78B

What is the all time high annual short term debt for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high annual short term debt is $4.28B

What is Teva Pharmaceutical Industries Limited annual short term debt year-on-year change?

Over the past year, TEVA annual short term debt has changed by +$109.00M (+6.52%)

What is Teva Pharmaceutical Industries Limited quarterly short term debt?

The current quarterly short term debt of TEVA is $421.00M

What is the all time high quarterly short term debt for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high quarterly short term debt is $4.37B

What is Teva Pharmaceutical Industries Limited quarterly short term debt year-on-year change?

Over the past year, TEVA quarterly short term debt has changed by -$2.64B (-86.24%)
On this page